BIOMAT Database Logo BIOMAT Database Logo

Posttransplant diabetes mellitus in pediatric thoracic organ recipients receiving tacrolimus-based immunosuppression. 2001

J A Paolillo, and G J Boyle, and Y M Law, and S A Miller, and K Lawrence, and K Wagner, and F A Pigula, and B P Griffith, and S A Webber
Department of Pediatrics, University of Pittsburgh School of Medicine, PA 15213, USA.

BACKGROUND Posttransplantation diabetes mellitus (PTDM) is a well-known complication of tacrolimus-based immunosuppression in both adult and pediatric solid organ recipients. The "natural history" of diabetes in the pediatric thoracic transplant population has not yet been described. METHODS We identified all pediatric thoracic transplant patients receiving tacrolimus-based immunosuppression who developed PTDM. Medical records were reviewed, with a particular focus on the clinical course of PTDM and its relationship to drug weaning. RESULTS Diabetes developed in 24 of 143 (17%) 30-day survivors of heart (12/96, 13%) and heart-lung/lung (12/ 47, 26%) transplantation. In 17 (71%) patients, the immunosuppressive regimen at the onset of PTDM also included maintenance corticosteroids. Seventeen patients demonstrated glucose intolerance before the onset of diabetes. Nine patients (38%) developed diabetes during pulsed corticosteroid therapy. Median time of onset after transplantation was 9.0 months. All patients required s.c. insulin for glucose control. The median follow-up from transplant was 49.9 months. There was a significant decrease in mean tacrolimus dosage (P<0.01), tacrolimus level (P<0.04), and steroid dosage (P<0.02) from onset of PTDM to most recent follow-up. Despite this significant reduction in immunosuppression, only 3/24 (13%) patients were successfully weaned off insulin. CONCLUSIONS Diabetes mellitus is a common complication in pediatric thoracic transplant patients receiving tacrolimus-based immunosuppression. Insulin dependence in our population rarely resolved, even after lowering tacrolimus and steroid doses. Discontinuation of steroids did not guarantee resolution of diabetes.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D013909 Thorax The upper part of the trunk between the NECK and the ABDOMEN. It contains the chief organs of the circulatory and respiratory systems. (From Stedman, 25th ed) Chest,Thoraces,Chests,Thorace
D016027 Heart Transplantation The transference of a heart from one human or animal to another. Cardiac Transplantation,Grafting, Heart,Transplantation, Cardiac,Transplantation, Heart,Cardiac Transplantations,Graftings, Heart,Heart Grafting,Heart Graftings,Heart Transplantations,Transplantations, Cardiac,Transplantations, Heart
D016040 Lung Transplantation The transference of either one or both of the lungs from one human or animal to another. Grafting, Lung,Transplantation, Lung,Graftings, Lung,Lung Grafting,Lung Graftings,Lung Transplantations,Transplantations, Lung
D016041 Heart-Lung Transplantation The simultaneous, or near simultaneous, transference of heart and lungs from one human or animal to another. Grafting, Heart-Lung,Transplantation, Heart-Lung,Grafting, Heart Lung,Graftings, Heart-Lung,Heart Lung Transplantation,Heart-Lung Grafting,Heart-Lung Graftings,Heart-Lung Transplantations,Transplantation, Heart Lung,Transplantations, Heart-Lung

Related Publications

J A Paolillo, and G J Boyle, and Y M Law, and S A Miller, and K Lawrence, and K Wagner, and F A Pigula, and B P Griffith, and S A Webber
New-onset diabetes mellitus in pediatric thoracic organ recipients receiving tacrolimus-based immunosuppression.
March 1997, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation,
J A Paolillo, and G J Boyle, and Y M Law, and S A Miller, and K Lawrence, and K Wagner, and F A Pigula, and B P Griffith, and S A Webber
Posttransplant diabetes mellitus in kidney transplant recipients under tacrolimus immunosuppression.
December 2000, Transplantation proceedings,
J A Paolillo, and G J Boyle, and Y M Law, and S A Miller, and K Lawrence, and K Wagner, and F A Pigula, and B P Griffith, and S A Webber
Posttransplant diabetes in pediatric recipients on tacrolimus.
March 1999, Transplantation,
J A Paolillo, and G J Boyle, and Y M Law, and S A Miller, and K Lawrence, and K Wagner, and F A Pigula, and B P Griffith, and S A Webber
Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression.
December 1999, Transplantation,
J A Paolillo, and G J Boyle, and Y M Law, and S A Miller, and K Lawrence, and K Wagner, and F A Pigula, and B P Griffith, and S A Webber
Posttransplant diabetes mellitus: a serious complication of immunosuppression in renal allograft recipients.
November 2002, Transplantation proceedings,
J A Paolillo, and G J Boyle, and Y M Law, and S A Miller, and K Lawrence, and K Wagner, and F A Pigula, and B P Griffith, and S A Webber
Posttransplant Diabetes Mellitus and Immunosuppression Selection in Older and Obese Kidney Recipients.
January 2022, Kidney medicine,
J A Paolillo, and G J Boyle, and Y M Law, and S A Miller, and K Lawrence, and K Wagner, and F A Pigula, and B P Griffith, and S A Webber
Posttransplant malignancies in pediatric organ transplant recipients.
October 1994, Transplantation proceedings,
J A Paolillo, and G J Boyle, and Y M Law, and S A Miller, and K Lawrence, and K Wagner, and F A Pigula, and B P Griffith, and S A Webber
Management of posttransplant lymphoproliferative disease in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy.
October 1998, Transplantation,
J A Paolillo, and G J Boyle, and Y M Law, and S A Miller, and K Lawrence, and K Wagner, and F A Pigula, and B P Griffith, and S A Webber
Diabetes mellitus after renal transplantation under tacrolimus-based immunosuppression.
February 2003, Transplantation proceedings,
J A Paolillo, and G J Boyle, and Y M Law, and S A Miller, and K Lawrence, and K Wagner, and F A Pigula, and B P Griffith, and S A Webber
Tacrolimus-associated posttransplant diabetes mellitus in renal transplant recipients: role of hepatitis C infection.
August 2002, Transplantation proceedings,
Copied contents to your clipboard!